NCT00929591View on ClinicalTrials.gov

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,558

Participants

Timeline

Start Date

May 31, 1989

Primary Completion Date

August 31, 2005

Study Completion Date

March 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

endocrine therapy

DRUG

endocrine-modulating drug therapy

DRUG

fluorouracil

DRUG

tamoxifen citrate

RADIATION

brachytherapy

RADIATION

low-LET electron therapy

RADIATION

low-LET photon therapy

RADIATION

radiation therapy

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

North Central Cancer Treatment Group

NETWORK

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

NCIC Clinical Trials Group

NETWORK

lead

SWOG Cancer Research Network

NETWORK

NCT00929591 - SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | Biotech Hunter | Biotech Hunter